Cargando…
Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6
PURPOSE: Sarcoidosis is a systemic granulomatous disease with unknown etiology. Many clinical presentations have been reported, and acute disease needs to be distinguished from subacute and chronic disease. The unpredictable clinical course of the disease prompted us to evaluate the clinical utility...
Autores principales: | Bergantini, Laura, Bianchi, Francesco, Cameli, Paolo, Mazzei, Maria Antonietta, Fui, Annalisa, Sestini, Piersante, Rottoli, Paola, Bargagli, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421736/ https://www.ncbi.nlm.nih.gov/pubmed/30944672 http://dx.doi.org/10.1155/2019/8565423 |
Ejemplares similares
-
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis
por: Bennett, David, et al.
Publicado: (2020) -
Correction to: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis
por: Bennett, David, et al.
Publicado: (2020) -
Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
por: d’Alessandro, Miriana, et al.
Publicado: (2021) -
Serial KL-6 measurements in COVID-19 patients
por: d’Alessandro, Miriana, et al.
Publicado: (2021) -
Serum Amyloid A in lung transplantation
por: Vietri, Lucia, et al.
Publicado: (2020)